|
English
|
正體中文
|
简体中文
|
2818750
|
|
???header.visitor??? :
28378846
???header.onlineuser??? :
608
???header.sponsordeclaration???
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"delaloge suzette"???jsp.browse.items-by-author.description???
Showing items 1-2 of 2 (1 Page(s) Totally) 1 View [10|25|50] records per page
臺大學術典藏 |
2022-08-12T06:38:49Z |
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
|
Martin, Miguel; Holmes, Frankie A; Ejlertsen, Bent; Delaloge, Suzette; Moy, Beverly; Iwata, Hiroji; von Minckwitz, Gunter; Chia, Stephen K L; Mansi, Janine; Barrios, Carlos H; Gnant, Michael; KING-JEN CHANG; et al., |
臺大學術典藏 |
2022-04-15T03:00:29Z |
Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis
|
Gelmon, Karen A; Fasching, Peter A; Couch, Fergus J; Balmaña, Judith; Delaloge, Suzette; Labidi-Galy, Intidhar; Bennett, James; CHIUN-SHENG HUANG; et al. |
Showing items 1-2 of 2 (1 Page(s) Totally) 1 View [10|25|50] records per page
|